Jeffrey Arvin Fink - Net Worth and Insider Trading

Jeffrey Arvin Fink Net Worth

The estimated net worth of Jeffrey Arvin Fink is at least $293 dollars as of 2024-11-13. Jeffrey Arvin Fink is the Director of Lipocine Inc and owns about 55 shares of Lipocine Inc (LPCN) stock worth over $293. Details can be seen in Jeffrey Arvin Fink's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Arvin Fink has not made any transactions after 2017-12-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey Arvin Fink

To

Jeffrey Arvin Fink Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Arvin Fink owns 1 companies in total, including Lipocine Inc (LPCN) .

Click here to see the complete history of Jeffrey Arvin Fink’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Arvin Fink

Ticker Comapny Transaction Date Type of Owner
LPCN Lipocine Inc 2017-12-29 director

Jeffrey Arvin Fink Latest Holdings Summary

Jeffrey Arvin Fink currently owns a total of 1 stock. Jeffrey Arvin Fink owns 55 shares of Lipocine Inc (LPCN) as of December 29, 2017, with a value of $293.

Latest Holdings of Jeffrey Arvin Fink

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPCN Lipocine Inc 2017-12-29 55 5.32 293

Holding Weightings of Jeffrey Arvin Fink


Jeffrey Arvin Fink Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey Arvin Fink has made a total of 0 transactions in Lipocine Inc (LPCN) over the past 5 years. The most-recent trade in Lipocine Inc is the sale of 55 shares on December 29, 2017, which brought Jeffrey Arvin Fink around $3,255.

Insider Trading History of Jeffrey Arvin Fink

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey Arvin Fink Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey Arvin Fink Ownership Network

Ownership Network List of Jeffrey Arvin Fink

No Data

Ownership Network Relation of Jeffrey Arvin Fink

Insider Network Chart

Jeffrey Arvin Fink Owned Company Details

What does Lipocine Inc do?

Who are the key executives at Lipocine Inc?

Jeffrey Arvin Fink is the director of Lipocine Inc. Other key executives at Lipocine Inc include director & President and CEO Mahesh V. Patel , Chief Medical Officer George Nomikos , and Principal Accounting Officer Krista Fogarty .

Lipocine Inc (LPCN) Insider Trades Summary

Over the past 18 months, Jeffrey Arvin Fink made no insider transaction in Lipocine Inc (LPCN). Other recent insider transactions involving Lipocine Inc (LPCN) include a net purchase of 8,706 shares made by Mahesh V. Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Lipocine Inc (LPCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lipocine Inc (LPCN) were sold and 8,706 shares were bought by its insiders, resulting in a net purchase of 8,706 shares.

Lipocine Inc (LPCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lipocine Inc Insider Transactions

No Available Data

Jeffrey Arvin Fink Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Arvin Fink. You might contact Jeffrey Arvin Fink via mailing address: 2265 Morning Star Drive, Park City Ut 84060.